FDA expands meningitis vaccine age range

Oct 18, 2007

The U.S. Food and Drug Administration has expanded the approved age range for Menactra, a bacterial meningitis vaccine.

Originally approved by the FDA in 2005 for use by people ages 11 to 55 years, it is now approved to include children ages 2 to 10 years.

Meningitis is a serious inflammation of the lining that surrounds the spinal cord and brain and can result in death or permanent injury.

Before Menactra's approval, Menomune was the only meningococcal vaccine available in the United States for use in children, ages 2 years and older. Both products are manufactured by Sanofi Pasteur Inc. of Swiftwater, Pa., and both offer protection against four groups of Neisseria meningitidis, the bacterium that can cause meningitis.

The Centers for Disease Control and Prevention recommends meningococcal vaccination for children ages 2 to 10 years who are at increased risk of meningococcal disease, such as those whose spleen has been removed; those with a medical condition that makes it difficult to fight infection; and those who expect to travel to areas where the disease is common.

Vaccination also is used to control outbreaks of bacterial meningitis.

Copyright 2007 by United Press International

Explore further: HHS leaders call for expanded use of medications to combat opioid overdose epidemic

add to favorites email to friend print save as pdf

Related Stories

Tablets, apps for children are on the rise

Apr 11, 2014

Nick Stepka knew what gift would make his daughter's third birthday a hit, and it wasn't a toy or doll. He gave her a tablet - not a sleek new iPad or a hand-me-down Samsung, but one specifically designed and marketed for ...

US secretly created 'Cuban Twitter' to stir unrest

Apr 03, 2014

In July 2010, Joe McSpedon, a U.S. government official, flew to Barcelona to put the final touches on a secret plan to build a social media project aimed at undermining Cuba's communist government.

Up in arms

Jan 28, 2014

In December 2012, when Adam Lanza stormed into the Sandy Hook Elementary School in Newtown, Conn., with a rifle and killed 20 children and six adult staff members, the United States found itself immersed ...

Recommended for you

FDA reconsiders behavior-modifying 'shock devices'

8 hours ago

(HealthDay)—They're likened to a dog's "shock collar" by some and called a "life-saving treatment" by others. But the days of electro-shock devices as a tool for managing hard-to-control behavior in people ...

FDA proposes accelerated medical device approval plan

Apr 23, 2014

(HealthDay)—The U.S. Food and Drug Administration has proposed a new program that would provide expedited access to high-risk medical devices intended for patients with serious conditions whose medical ...

Targeting drugs to reduce side effects

Apr 23, 2014

(Medical Xpress)—Consider ice cream – the base of which is frozen cream. Ingredients are then added to make different flavours. All these flavours are distinctly different but are created from the same foundation.

User comments : 0

More news stories

Genetic code of the deadly tsetse fly unraveled

Mining the genome of the disease-transmitting tsetse fly, researchers have revealed the genetic adaptions that allow it to have such unique biology and transmit disease to both humans and animals.